[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Recombinant Vaccine Market Research Report 2018

April 2018 | 103 pages | ID: C12BCDC6306EN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Recombinant Vaccine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Recombinant Vaccine development status and future trend in China, focuses on top players in China, also splits Recombinant Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Merck & Co., Inc.
  • Green Cross Corporation
  • Pfizer, Inc.
  • Sanofi S A.
  • Protein Science Corporation
  • GlaxoSmithKline Plc
  • Novartis AG
  • Bharat Biotech
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
  • Subunit Recombinant Vaccines
  • Attenuated Recombinant Vaccines
  • Vector Recombinant Vaccines
On the basis of the end users/application, this report covers
  • Human
  • Animal
If you have any special requirements, please let us know and we will offer you the report as you want.
China Recombinant Vaccine Market Research Report 2018

1 RECOMBINANT VACCINE OVERVIEW

1.1 Product Overview and Scope of Recombinant Vaccine
1.2 Classification of Recombinant Vaccine by Product Category
  1.2.1 China Recombinant Vaccine Sales (K Doses) Comparison by Type (2013-2025)
  1.2.2 China Recombinant Vaccine Sales (K Doses) Market Share by Type in 2017
  1.2.3 Subunit Recombinant Vaccines
  1.2.4 Attenuated Recombinant Vaccines
  1.2.5 Vector Recombinant Vaccines
1.3 China Recombinant Vaccine Market by Application/End Users
  1.3.1 China Recombinant Vaccine Sales (K Doses) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Human
  1.3.3 Animal
1.4 China Recombinant Vaccine Market by Region
  1.4.1 China Recombinant Vaccine Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Recombinant Vaccine Status and Prospect (2013-2025)
  1.4.3 East China Recombinant Vaccine Status and Prospect (2013-2025)
  1.4.4 Southwest China Recombinant Vaccine Status and Prospect (2013-2025)
  1.4.5 Northeast China Recombinant Vaccine Status and Prospect (2013-2025)
  1.4.6 North China Recombinant Vaccine Status and Prospect (2013-2025)
  1.4.7 Central China Recombinant Vaccine Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Recombinant Vaccine (2013-2025)
  1.5.1 China Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
  1.5.2 China Recombinant Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA RECOMBINANT VACCINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Recombinant Vaccine Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Recombinant Vaccine Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Recombinant Vaccine Average Price (USD/Dose) by Players/Manufacturers (2013-2018)
2.4 China Recombinant Vaccine Market Competitive Situation and Trends
  2.4.1 China Recombinant Vaccine Market Concentration Rate
  2.4.2 China Recombinant Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Recombinant Vaccine Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA RECOMBINANT VACCINE SALES AND REVENUE BY REGION (2013-2018)

3.1 China Recombinant Vaccine Sales (K Doses) and Market Share by Region (2013-2018)
3.2 China Recombinant Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Recombinant Vaccine Price (USD/Dose) by Regions (2013-2018)

4 CHINA RECOMBINANT VACCINE SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Recombinant Vaccine Sales (K Doses) and Market Share by Type/ Product Category (2013-2018)
4.2 China Recombinant Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Recombinant Vaccine Price (USD/Dose) by Type (2013-2018)
4.4 China Recombinant Vaccine Sales Growth Rate (%) by Type (2013-2018)

5 CHINA RECOMBINANT VACCINE SALES BY APPLICATION (2013-2018)

5.1 China Recombinant Vaccine Sales (K Doses) and Market Share by Application (2013-2018)
5.2 China Recombinant Vaccine Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA RECOMBINANT VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Green Cross Corporation
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Green Cross Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pfizer, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer, Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sanofi S A.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi S A. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Protein Science Corporation
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Protein Science Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline Plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Recombinant Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Plc Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Recombinant Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bharat Biotech
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Recombinant Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bharat Biotech Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview

7 RECOMBINANT VACCINE MANUFACTURING COST ANALYSIS

7.1 Recombinant Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA RECOMBINANT VACCINE MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Recombinant Vaccine Sales (K Doses), Revenue (Million USD) Forecast (2018-2025)
11.2 China Recombinant Vaccine Sales (K Doses) Forecast by Type (2018-2025)
11.3 China Recombinant Vaccine Sales (K Doses) Forecast by Application (2018-2025)
11.4 China Recombinant Vaccine Sales (K Doses) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Recombinant Vaccine Sales (K Doses) and Revenue (Million USD) Market Split by Product Type
Table Recombinant Vaccine Sales (K Doses) by Application (2013-2025)
Figure Product Picture of Recombinant Vaccine
Table China Recombinant Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Recombinant Vaccine Sales Volume Market Share by Types in 2017
Figure Subunit Recombinant Vaccines Product Picture
Figure Attenuated Recombinant Vaccines Product Picture
Figure Vector Recombinant Vaccines Product Picture
Figure China Recombinant Vaccine Sales (K Doses) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Recombinant Vaccine by Application in 2017
Figure Human Examples
Table Key Downstream Customer in Human
Figure Animal Examples
Table Key Downstream Customer in Animal
Figure South China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Recombinant Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
Figure China Recombinant Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Recombinant Vaccine Sales of Key Players/Manufacturers (2013-2018)
Table China Recombinant Vaccine Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Recombinant Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 China Recombinant Vaccine Sales Share (%) by Players/Manufacturers
Table China Recombinant Vaccine Revenue by Players/Manufacturers (2013-2018)
Table China Recombinant Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Recombinant Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Recombinant Vaccine Revenue Market Share (%) by Players/Manufacturers
Table China Market Recombinant Vaccine Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Recombinant Vaccine Average Price of Key Players/Manufacturers in 2017
Figure China Recombinant Vaccine Market Share of Top 3 Players/Manufacturers
Figure China Recombinant Vaccine Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Recombinant Vaccine Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Recombinant Vaccine Product Category
Table China Recombinant Vaccine Sales (K Doses) by Regions (2013-2018)
Table China Recombinant Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Recombinant Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Recombinant Vaccine Sales Market Share (%) by Regions in 2017
Table China Recombinant Vaccine Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Recombinant Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Recombinant Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Recombinant Vaccine Revenue Market Share (%) by Regions in 2017
Table China Recombinant Vaccine Price (USD/Dose) by Regions (2013-2018)
Table China Recombinant Vaccine Sales (K Doses) by Type (2013-2018)
Table China Recombinant Vaccine Sales Share (%) by Type (2013-2018)
Figure China Recombinant Vaccine Sales Share (%) by Type (2013-2018)
Figure China Recombinant Vaccine Sales Market Share (%) by Type in 2017
Table China Recombinant Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Recombinant Vaccine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type (2013-2018)
Figure Revenue Market Share of Recombinant Vaccine by Type in 2017
Table China Recombinant Vaccine Price (USD/Dose) by Types (2013-2018)
Figure China Recombinant Vaccine Sales Growth Rate (%) by Type (2013-2018)
Table China Recombinant Vaccine Sales (K Doses) by Applications (2013-2018)
Table China Recombinant Vaccine Sales Market Share (%) by Applications (2013-2018)
Figure China Recombinant Vaccine Sales Market Share (%) by Application (2013-2018)
Figure China Recombinant Vaccine Sales Market Share (%) by Application in 2017
Table China Recombinant Vaccine Sales Growth Rate (%) by Application (2013-2018)
Figure China Recombinant Vaccine Sales Growth Rate (%) by Application (2013-2018)
Table Merck & Co., Inc. Recombinant Vaccine Basic Information List
Table Merck & Co., Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Merck & Co., Inc. Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Green Cross Corporation Recombinant Vaccine Basic Information List
Table Green Cross Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Green Cross Corporation Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Pfizer, Inc. Recombinant Vaccine Basic Information List
Table Pfizer, Inc. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Pfizer, Inc. Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Sanofi S A. Recombinant Vaccine Basic Information List
Table Sanofi S A. Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Sanofi S A. Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Sanofi S A. Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Protein Science Corporation Recombinant Vaccine Basic Information List
Table Protein Science Corporation Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Protein Science Corporation Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline Plc Recombinant Vaccine Basic Information List
Table GlaxoSmithKline Plc Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline Plc Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Novartis AG Recombinant Vaccine Basic Information List
Table Novartis AG Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Novartis AG Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Novartis AG Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Novartis AG Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Bharat Biotech Recombinant Vaccine Basic Information List
Table Bharat Biotech Recombinant Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Bharat Biotech Recombinant Vaccine Sales Market Share (%) in China (2013-2018)
Figure Bharat Biotech Recombinant Vaccine Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Vaccine
Figure Manufacturing Process Analysis of Recombinant Vaccine
Figure Recombinant Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Vaccine Major Players/Manufacturers in 2017
Table Major Buyers of Recombinant Vaccine
Table Distributors/Traders List
Figure China Recombinant Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure China Recombinant Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Recombinant Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table China Recombinant Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure China Recombinant Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure China Recombinant Vaccine Sales Volume Market Share Forecast by Type in 2025
Table China Recombinant Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure China Recombinant Vaccine Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Recombinant Vaccine Sales Volume Market Share Forecast by Application in 2025
Table China Recombinant Vaccine Sales (K Doses) Forecast by Regions (2018-2025)
Table China Recombinant Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Recombinant Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Recombinant Vaccine Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories